Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
CRVS logo

CRVS

NSD
Corvus Pharmaceuticals Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Monday 7th July 2025
3.95
-0.03 (-0.75%)
Prev Close:3.98
Open:4.02
Bid:3.93
Ask:4.02
52 Week Range
1.77
10.00
Volume:1,137,610
Mkt Cap:298 M
Price Target
$4.54
+14.9%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

CRVS - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Invalid date
Depreciation And Amortization100000.0200000.0400000.0500000.0
Earnings From Equity Interest-3 M-5 M
Earnings From Equity Interest Net Of Tax-3 M-5 M
Gain On Sale Of Business37 M
Gain On Sale Of PPE5000.022000.0
Gain On Sale Of Security2 M2 M-10 M-5 M-234000.0
General And Administrative Expense8 M7 M8 M10 M12 M11 M11 M10 M8 M
Interest Expense Non Operating15000.0
Misc Other Special Charges-33 M78000.0
Net Income (loss)-62 M-27 M-41 M-43 M-6 M-47 M-47 M-56 M-36 M
Net Income Common Stockholders-62 M-27 M-41 M-43 M-6 M-47 M-47 M-56 M-36 M
Net Income Continuous Operations-62 M-27 M-41 M-43 M-6 M-47 M-47 M-56 M-36 M
Net Income From Other Gains Losses185000.0540000.02 M2 M861000.0601000.0
Net Non Operating Interest Income Expense-2 M-654000.0
Normalized Income-59 M
Operating Income-28 M-23 M-33 M-39 M-44 M-49 M-49 M-57 M-37 M
Operating Income Before Depreciation (EBITDA)-62 M-27 M-41 M-38 M-43 M-48 M-48 M-56 M-36 M
Operating Expense28 M23 M33 M39 M44 M49 M49 M-57 M-37 M
Other Gand A8 M7 M8 M10 M12 M11 M11 M10 M8 M
Other Operating Expenses-296000.0-222000.0-216000.0-347000.0-10 M-446000.0-49 M
Rent And Landing Fees-748000.010 M8 M
Research Expense19 M17 M24 M29 M32 M38 M39 M46 M29 M
Salaries And Wages3 M2 M3 M-7 M-6 M
Total Income Available For Interest Expense (EBIT)-62 M-27 M-41 M-39 M-44 M-49 M-49 M-57 M-37 M
Total Expenses28 M23 M33 M39 M44 M49 M49 M-57 M-37 M
Avgshs61 M48 M47 M42 M29 M29 M28 M20 M15 M
Avgshsdt61 M48 M47 M42 M29 M28 M20 M15 M
Basiceps-1.02-0.56-0.89-1.03-0.2-1.59
Basicepscont-1.02-0.56-0.89-1.03-0.2-1.59
Depamor100000.0200000.0400000.0500000.0
Dileps-1.02-0.56-0.89-1.03-0.2-1.59-1.71-2.72-2.36
Dilepscont-1.02-0.56-0.89-1.03-1.71
Netincdisc-62 M-27 M-41 M-43 M-6 M-47 M-47 M-56 M-36 M
Othincexp35 M4 M-9 M5 M-37 M
Pretaxinc-59 M-22 M-41 M-43 M-7 M-49 M-49 M-57 M-37 M
Resdev19 M17 M24 M29 M32 M38 M39 M46 M29 M
Sga8 M7 M8 M10 M12 M11 M11 M10 M8 M
Shsout68 M49 M47 M47 M38 M29 M29 M21 M21 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader